CrossRef enabled

PAC Archives

Archive →

Pure Appl. Chem., 2003, Vol. 75, No. 11-12, pp. 1757-1769

Estrogen receptor action through target genes with classical and alternative response elements

P. J. Kushner, P. Webb, R. M. Uht, M.-M. Liu and R. H. Price, Jr.

Department of Medicine, University of California, San Francisco, CA 94115-1640, USA

CrossRef Cited-by theme picture

CrossRef Cited-by Linking

  • Saxena Ruchi, Fatima Iram, Chandra Vishal, Blesson Chellakkan S., Kharkwal Geetika, Hussain Mohammad K., Hajela Kanchan, Roy Bal G., Dwivedi Anila: Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft. Steroids 2013, 78, 1071. <>
  • Chandra Vishal, Fatima Iram, Saxena Ruchi, Kitchlu Shakti, Sharma Sharad, Hussain Mohammad Kamil, Hajela Kanchan, Bajpai Preeti, Dwivedi Anila: Apoptosis induction and inhibition of hyperplasia formation by 2-[piperidinoethoxyphenyl]-3-[4-hydroxyphenyl]-2H-benzo(b)pyran in rat uterus. Am J Obset Gynecol 2011, 205, 362.e1. <>
  • Hsia Elaine Y., Goodson Michael L., Zou June X., Privalsky Martin L., Chen Hong-Wu: Nuclear receptor coregulators as a new paradigm for therapeutic targeting. Adv Drug Delivery Rev 2010, 62, 1227. <>
  • Budhram-Mahadeo Vishwanie S, Latchman David S: Targeting Brn-3b in breast cancer therapy. eott 2006, 10, 15. <>
  • Pearce Kenneth H., Iannone Marie A., Simmons Catherine A., Gray John G.: Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling. drug discov today 2004, 9, 741. <>